LOADING
Comparing Merck & Company (MRK) and Boeing Company (BA) across the Health Care and Industrials sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | BA |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $283.8B | $180.5B |
| P/E Ratio | 32.4 | 90.1 |
| Forward P/E | 22.7 | 833.3 |
| PEG Ratio | 5.34 | 23.73 |
| EPS | $3.55 | $2.54 |
| Revenue Growth (YoY) | 4.9% | 14.0% |
| Profit Margin | 13.6% | 2.5% |
| Return on Equity | 18.9% | 170.0% |
| Dividend Yield | 2.77% | -- |
| Beta | 0.22 | 1.20 |
| 52-Week High | $123.33 | $254.35 |
| 52-Week Low | $74.18 | $176.77 |
| Volume | -- | -- |
Merck & Company is the larger company by market capitalization. Merck & Company trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Merck & Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.